Open Access
Ann Toxicol Anal
Volume 20, Numéro 4, 2008
Page(s) 165 - 179
Publié en ligne 19 mars 2009
  1. Malone K, Papagni K, Ramini S, Keltner NL. Antidepressants, antipsychotics, benzodiazepines, and the breastfeeding dyad. Perspect Psychiatr Care. 2004; 40(2): 73–85. [CrossRef] [PubMed]
  2. Lambré C. Les risques liés aux contaminants chimiques dans le lait maternel. J Pédiatr Puériculture. 2002; 15: 11–16. [CrossRef]
  3. Turck D. Allaitement maternel : les bénéfices pour la santé de l'enfant et de sa mère. Arch Pediatr. 2005; 12: S145–S165. [CrossRef] [PubMed]
  4. American Academy of Pediatrics. Breastfeeding and the use of human milk. Work Group on Breastfeeding. Pediatrics. 1997; 100: 1035–1039. [CrossRef] [PubMed]
  5. Escobar AMU, Ogawa AR, Hiratsuka M, Kawashita MY, Teruya PY, Grisi S, Tomikawa SO. Aleitamento e condições socioeconômico-culturais: fatores que levam ao desmame precoce. Rev Bras Saude Mater Infant. 2002; 2: 253–261. [CrossRef]
  6. Cunningham AS, Jelliffe DB, Jelliffe EF. Breast-feeding and health in the 1980s: a global epidemiologic review. J Pediatr. 1991; 118: 659–666. [CrossRef] [PubMed]
  7. Tanaka PA, Yeung DL, Anderson GH. Infant feeding practices: 1984-1985 versus 1977-1978. Can Med Assoc J. 1987; 136: 940–944. [PubMed]
  8. Gremmo-Féger G, Dobrzynski M, Collet M. Allaitement maternel et médicaments. J Gynecol Obstet Biol Reprod. 2003; 32: 466–475.
  9. Jones W, Brown D. The medication vs. breastfeeding dilemma. Br J Midwifery. 2003; 11: 550–555.
  10. Amir LH. Medicines and breastfeeding: information is available on safe use. Med J Aust. 2007; 186(9): 485. [PubMed]
  11. Beaufrère B, Bresson JL, Briend A, Ghisolfi J, Goulet O, Navarro J, Putet G, Ricour C, Rieu D, Turck D, Vidailhet M. La promotion de l'allaitement maternel : c'est aussi l'affaire des pédiatres. Arch Pediatr. 2000; 7: 1149–1153. [CrossRef] [PubMed]
  12. Newman J. What drugs can I take while breastfeeding? Can J Diagnosis. 1998; 15: 105–120.
  13. Howard CR, Lawrence RA. Drugs and breastfeeding. Clin Perinatol 1999; 26: 447–478.
  14. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001; 108: 776–789. [PubMed]
  15. Lamounier JA, Cabral CM, Oliveira BC, Oliveira AB, Júnior AMO, Silva APA. O uso de medicamentos em puérperas interfere nas recomendações ao aleitamento materno? J Pediatr (Rio J). 2002; 78: 57–61.
  16. Lacroix I, Arrault-Olanor A, Berrebi A, Montastruc J-L, Damase-Michel C. Consommation de médicaments en période périnatale : étude comparative chez des femmes allaitant ou non leur enfant. J Pédiatr Puériculture. 2005; 18: 379–385. [CrossRef]
  17. Centre national d'information sur le médicament hospitalier. Médicaments et allaitement. Dossier du CNIMH. 1996; XVII(10): 5–6.
  18. Matheson I, Kristensen K, Lunde PKM. Drug utilization in breast-feeding women: a survey in Oslo. Eur J Clin Pharmacol. 1990; 38: 453–459. [CrossRef] [PubMed]
  19. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993; 168: 1393–1399. [CrossRef] [PubMed]
  20. Wisner KL, Peindl KP, Hanusa BH. Relationship of psychiatric illness to childbearing status: a hospital-based epidemiologic study. J Affect Disord. 1993; 28: 39–50. [CrossRef] [PubMed]
  21. Patrick MJ, Tilstone WJ, Reavey P. Diazepam and breastfeeding. Lancet. 1972; 1: 542–543. [CrossRef]
  22. Erikkola R, Kanto J. Diazepam and breast-feeding. Lancet. 1972; 1: 1235–1236. [CrossRef]
  23. Cole AP, Hailey DM. Diazepam and active metabolite in breast milk and their transfer to the neonate. Arch Dis Child. 1975; 50: 741–742. [CrossRef] [PubMed]
  24. Dusci LJ, Good SM, Hall RW, Ilett KF. Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam. Br J Clin Pharmacol. 1990; 29: 123–126. [CrossRef] [PubMed]
  25. Birnbaum CS, Cohen LS, Bailey JW, Grush LR, Robertson BA, Stowe ZN. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series. Pediatrics. 1999; 104(1): e11.
  26. Borgatta L, Jenny RW, Gruss L, Ong C, Barad D. Clinical significance of methohexital, meperidine, and diazepam in breast milk. J Clin Pharmacol. 1997; 37(3): 186–192. [CrossRef] [PubMed]
  27. Hilbert JM, Gural RP, Symchowicz S, Zamaglione N. Excretion of quazepam into human breast milk. J Clin Pharmacol. 1984; 24(10): 457–462. [CrossRef] [PubMed]
  28. Wretlind M. Excretion of oxazepam in breast milk. Eur J Clin Pharmacol. 1987; 33: 209–211. [CrossRef] [PubMed]
  29. Matheson I, Lunde PKM, Bredesen JE. Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects. Br J Clin Pharmacol. 1990; 30: 787–793. [CrossRef] [PubMed]
  30. Lemmer P, Schneider S, Mühe A, Wennig R. Quantification of lorazepam and lormetazepam in human breast milk using GC-MS in the negative chemical ionozition mode. J Anal Toxicol. 2007; 31: 224–226. [CrossRef] [PubMed]
  31. Pons G, Rey E. Passage des médicaments dans le lait. In : Brion F, Cabrol D, Moriette G, Pons G. Les médicaments en périnatologie. Paris : Masson 2003 : 17–26.
  32. Neville MC, Allen JC, Watters C. The mechanisms of milk secretion. In : Neville MC, Neifert MR. New York : Lactation editions 1983 : 50.
  33. McManaman JL, Neville MC. Mammary physiology and milk secretion. Adv Drug Deliv Rev. 2003; 55: 629–641. [CrossRef] [PubMed]
  34. Hale TW. Medications and mothers'milk (10th edition) Amarillo, Tx : Pharmasoft Medical Publishing. 2002 : 266–270.
  35. Bavoux F, Warot D. Allaitement et médicament. In : Brion F, Cabrol D, Moriette G, Pons G. Les médicaments en périnatologie. Paris : Masson 2003 : 347–354.
  36. Damase-Michel C, Rolland M, Assouline C, Tricoire J, Lacroix I. Médicaments et allaitement maternel. EMC-Médecine. 2004; 1: 417–432. [CrossRef]
  37. Lee KG. Lactation and drugs. J Paediatr Child Health. 2007; 17(2): 68–71. [CrossRef]
  38. Fleishaker JC, Desai N, McNamara PJ. Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat. J Pharm Sci. 1987; 76: 189–193. [CrossRef] [PubMed]
  39. Fleishaker JC, McNamara PJ. In vivo evaluation in the lactating rabbit of a model for xenobiotic distribution into breast milk. J Pharmacol Exp Ther. 1988; 244: 919–924. [PubMed]
  40. Fleishaker JC. Models and methods for predicting drug transfer into human milk. Adv Drug Deliv Rev. 2003; 55: 643–652. [CrossRef] [PubMed]
  41. Rasmussen F. Mammary excretion of sulphonamides. Acta Pharmacol Toxicol. 1958; 15: 139–148. [CrossRef]
  42. Rasmussen F. Mammary excretion of benzylpenicillin, erythromycin, and penethamate hydroiodide. Acta Pharmacol Toxicol. 1959; 16: 194–200. [CrossRef]
  43. Rasmussen F. Excretion of drugs by milk, in concepts in biochemical pharmacology. In : Brodie BB, Gillette JR. Berlin : Springer 1971 : 390–402.
  44. Oo CY, Kuhn RJ, Desai N, McNamara PJ. Active transport of cimetidine into human milk. Clin Pharmacol Ther. 1995; 58: 548–555. [CrossRef] [PubMed]
  45. Gerk PM, Kuhn RJ, Desai NS, McNamara PJ. Active transport of nitrofurantoin into human milk. Pharmacotherapy. 2001; 21: 669–675. [CrossRef] [PubMed]
  46. Pons G, Francoual C, Guillet Ph, Moran C, Hermann P, Bianchetti G, Thiercelin JF, Thenot JP, Olive G. Zolpidem excretion in breast milk. Eur J Clin Pharmacol. 1989; 37: 245–248. [CrossRef] [PubMed]
  47. Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004; 80: S189–S198. [CrossRef] [PubMed]
  48. Wilson JT, Don Brown R, Cherek PR, Dailey JW, Hilman B, Jobe PC, Manno BR. Drug excretion in human breast milk. Principles, pharmacokinetics and projected consequences. Clin Pharmacokinet. 1980; 5: 1–66. [CrossRef] [PubMed]
  49. Begg EJ, Duffull SB, Hackett LP, Ilett KF. Studying drugs in human milk: Time to unify the approach. J Hum Lact. 2002; 18: 323–332. [CrossRef] [PubMed]
  50. Howard CR, Lawrence RA. Xenobiotics and breastfeeding. Pediatr Clin North Am. 2001; 48: 485–504. [CrossRef] [PubMed]
  51. Cregan MD, Hartmann PE. Computerized breast measurement from conception to weaning: clinical implications. J Hum Lact. 1999; 15: 89–96. [CrossRef] [PubMed]
  52. De Schuiteneer B, Coninck N. Médicaments et allaitement (2nd edn). Arnette Blackwell, 1996.
  53. Belton EM, Jones RV. Haemolytic anaemia due to nalidixic acid. Lancet. 1965; 2: 691. [CrossRef] [PubMed]
  54. Varsano I, Fischl J, Shochet SB. The excretion of orally ingested nitrofurantoin in human milk. J Pediatr. 1973; 82: 886–887. [CrossRef] [PubMed]
  55. Ito S, Lee A. Drug excretion into breast milk - Overview. Adv Drug Deliv Rev. 2003; 55: 617–627. [CrossRef] [PubMed]
  56. Ito S, Koren G. A novel index for expressing exposure of the infant to drugs in breast milk. Br J Clin Pharmacol. 1994; 38: 99–102. [CrossRef] [PubMed]
  57. Ito S. Drug therapy for breast-feeding women. N Engl J Med. 2000; 343: 118–126. [CrossRef] [PubMed]
  58. Wilson JT, Don Brown R, Hinson JL, Dailey JW. Pharmacokinetic pitfalls in the estimation of the breast milk/plasma ratio for drugs. Ann Rev Pharmacol Toxicol. 1985; 25: 667–689. [CrossRef]
  59. Larsen LA, Ito S, Koren G. Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother. 2003; 37(9): 1299–1306. [CrossRef] [PubMed]
  60. O'Hara MW, Swain AM. Rates and risk of postpartum depression: a meta-analysis. Int Rev Psychiatry. 1996; 8: 37–54. [CrossRef]
  61. Hagg S, Spigset O. Anticonvulsant use during lactation. Drug Saf. 2000; 22: 425–440. [CrossRef] [PubMed]
  62. Deglin JH, Vallerand AH. Davis's drug guide for nurses (8th edn). Philadelphia : Davis, 2003.
  63. Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ. Pharmacokinetics in lactating women: Prediction of alprazolam transfer into milk. Br J Clin Pharmacol. 1995; 40: 231–236. [CrossRef] [PubMed]
  64. Suri RA, Altshuler LL, Burt VK, Hendrick VC. Managing psychiatric medications in the breast-feeding woman. Medscape Womens Health.1998; 3(1).
  65. Nitsun M, Szokol JW, Saleh HJ, Murphy GS, Vender JS, Luong L, Raikoff K, Avram MJ. Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk. Clin Pharmacol Ther. 2006; 79(6): 549–557. [CrossRef] [PubMed]
  66. Lebedevs TH, Wojnar-Horton RE, Yapp P, Roberts MJ, Dusci LJ, Hackett LP, Ilett KF. Excretion of temazepam in breast milk. Br J Clin Pharmacol. 1992; 33: 204–206. [CrossRef] [PubMed]
  67. Humpel M, Stoppelli I, Rainer E. Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. Eur J Clin Pharmacol. 1982; 21: 421–425. [CrossRef] [PubMed]
  68. Brandt R. Passage of diazepam and N-desmethyldiazepam into breast milk. Arzneim Forsch. 1976; 26: 454–457.
  69. Summerfield RJ, Neilsen MS. Excretion of lorazepam into breast milk. Br J Anaesth. 1985; 57: 1042–1043. [CrossRef] [PubMed]
  70. Soderman P, Matheson I. Clonazepam in breast milk. Eur J Pediatr. 1988; 147: 212–213. [CrossRef] [PubMed]
  71. Kanto JH, Aaltonen L, Kangas L, Erkkola R, Pitkanen Y. Placental transfer and breast milk levels of flunitrazepam. Curr Ther Res. 1979; 26: 539–545.
  72. Reider J, Wendt G. Pharmacokinetics and metabolism of the hypnotic nitrazepam. In : Garratini S, Mussini E, Randall LO. The benzodiazepines. New York : Raven Press 1973 : 99–127.
  73. McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol. 1994; 8(6): 461–475. [CrossRef] [PubMed]
  74. Morselli PL, Principi N, Tognoni G, Reali E, Belvedere G, Standen SM, Sereni F. Diazepam elimination in premature and full term infants and children. J Perinat Med. 1973; 1(2): 133–141. [CrossRef] [PubMed]
  75. Rane A. Drug metabolism and disposition in infants and children. In: Yaffe SJ, Aranda JV. Neonatal and pediatric pharmacology - therapeutic principles in practice (3rd edn). Philadelphia : Lippincott, Williams & Wilkins 2005 : 32–43.
  76. Dencker SJ, Johansson G, Milsom I. Quantification of naturally occurring benzodiazepine-like substances in human breast milk. Psychopharmacology. 1992; 107: 69–72. [CrossRef] [PubMed]
  77. Burt V, Suri R, Altshuler L, Stowe Z, Hendrick VC, Muntean E. The use of psychotropic medications during breast-feeding. Am J Psychiatry. 2001; 158: 1001–1009. [CrossRef] [PubMed]
  78. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. Bioanalytical method validation - a revisit with decade of progress. Pharm Res. 2000; 17(12): 1551–1557. [CrossRef] [PubMed]
  79. Atkinson HC, Begg EJ, Darlow BA. Drugs in human milk. Clinical pharmacokinetic considerations. Clin Pharmacokinet. 1988; 14: 217–240. [CrossRef] [PubMed]
  80. VIDAL (http://srv-vidal/medicaments; 6 novembre 2008).